Trinity Biotech annual total assets
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Trinity Biotech Total Assets Growth & History (TRIB)
Trinity Biotech's total assets was $105.2M for fiscal 2025.
View full Trinity Biotech company overviewTrinity Biotech annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $105.2M | $1.9M | +1.82% |
| 2024 | 2024-12-31 | $103.3M | $43.9M | +73.79% |
| 2023 | 2023-12-31 | $59.4M | −$32.7M | −35.47% |
| 2022 | 2022-12-31 | $92.1M | −$26.8M | −22.53% |
| 2021 | 2021-12-31 | $118.9M | −$11.5M | −8.82% |
| 2020 | 2020-12-31 | $130.4M | −$674,000 | −0.51% |
| 2019 | 2019-12-31 | $131.1M | −$20.6M | −13.58% |
| 2018 | 2018-12-31 | $151.7M | −$41.3M | −21.41% |
| 2017 | 2017-12-31 | $193.0M | −$56.6M | −22.68% |
| 2016 | 2016-12-31 | $249.6M | — | — |
Trinity Biotech quarterly total assets
Q4.16
Q4.17
Q2.18
Q4.18
Q4.19
Q4.20
Q4.21
Q2.22
Q4.22
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $105.2M | $1.9M | +1.82% |
| Q2 2025 | 2025-06-30 | $99.6M | $5.3M | +5.59% |
| Q4 2024 | 2024-12-31 | $103.3M | $43.9M | +73.79% |
| Q2 2024 | 2024-06-30 | $94.4M | — | — |
| Q4 2023 | 2023-12-31 | $59.4M | −$32.7M | −35.47% |
| Q4 2022 | 2022-12-31 | $92.1M | −$26.8M | −22.53% |
| Q2 2022 | 2022-06-30 | $107.1M | — | — |
| Q4 2021 | 2021-12-31 | $118.9M | −$11.5M | −8.82% |
| Q4 2020 | 2020-12-31 | $130.4M | −$674,000 | −0.51% |
| Q4 2019 | 2019-12-31 | $131.1M | −$20.6M | −13.58% |
| Q4 2018 | 2018-12-31 | $151.7M | −$41.3M | −21.41% |
| Q2 2018 | 2018-06-30 | $194.4M | — | — |
| Q4 2017 | 2017-12-31 | $193.0M | −$56.6M | −22.68% |
| Q4 2016 | 2016-12-31 | $249.6M | — | — |
Trinity Biotech total assets trends
Over the last five fiscal years, Trinity Biotech's total assets decreased from $130.4M to $105.2M, a change of −$25.2M. The latest reported quarter, Q4 2025, shows $105.2M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Trinity Biotech source filings ↗